V

VCEL

Vericel

35.63

0.69+1.97%
After Hours: 34.92  -0.71  -1.99%19:02 08/01 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE34.38/34.94
TODAY RANGE33.09-36.05
VOL962.79K
MARKET CAP1.79B
52 WEEK RANGE33.09-63.00
AVG VOL (3M)557.86K
% TURNOVER1.91%
TURNOVER--
P/E (TTM)501.13
% RANGE8.20%
EPS(TTM)0.0711
P/E(FORWARD)142.52
P/B5.86
BVPS6.08
DIVIDEND--
P/S7.45
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.77B
SHARES OUTSTANDING50.34M
NEXT EARNINGS11/05-11/10
FREE FLOAT49.81M
LOT SIZE1
EX-DATE10/16/2013
Same Industry
Name/Symbol
Change%
Price

V

Vericel

VCEL

+1.97%
35.63

M

McKesson

MCK

+0.76%
698.80

B

Biogen Inc

BIIB

+3.09%
131.95

A

Amgen Inc

AMGN

+0.60%
296.88

S

Shire

SHPG

--
179.20

B

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

0.00%
0.0301

L

Lilly Eli & Co

LLY

+3.01%
762.33

C

Celgene

CELG

--
108.24

T

Therapeuticsmd Inc

TXMD

-0.89%
1.11

J

Johnson & Johnson

JNJ

+1.57%
167.33

A

Abbvie Inc

ABBV

+3.28%
195.22

Z

Zoetis Inc

ZTS

+1.09%
147.38

G

Gilead Sciences Inc

GILD

+0.79%
113.18

N

Novo-Nordisk A/S

NVO

+2.38%
48.19

B

Bristol-Myers Squibb Co

BMY

+2.12%
44.23

A

Alexion Pharms

ALXN

+1.70%
182.50

P

Pfizer

PFE

+0.86%
23.49

S

Sanofi FR

SNY

+2.43%
46.75

S

Sanofi FR

GCVRZ

0.00%
0.8711

N

Novartis

NVS

+1.37%
115.30

D

Dr Reddys Labs

RDY

-1.97%
13.94
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.